The Pamela study: Main findings and perspectives

Current Hypertension Reports

Volumn 15, Issue 3, 2013, Pages 238-243

  Bombelli, Michele ^a   Toso, Elena ^a   Peronio, Maria ^a   Fodri, Danilo ^a   Volpe, Marco ^a   Brambilla, Gianmaria ^a   Facchetti, Rita ^a   Sega, Roberto ^a   Grassi, Guido ^a,b   Mancia, Giuseppe ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

Ambulatory blood pressure; Blood glucose; Body mass index; Clinical blood pressure; Home blood pressure; Left ventricular mass index; Masked hypertension; Metabolic syndrome; Waist circumference; White coat hypertension

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FATALITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MASKED HYPERTENSION; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WHITE COAT HYPERTENSION;

BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; ITALY; PROGNOSIS;

EID: 84877823607     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0348-1     Document Type: Article

References (25)

1. Cesana G, De Vito G, Ferrario M, et al. Ambulatory blood pressure normalcy: the PAMELA Study. J Hypertens Suppl. 1991;9:S17-23.
2. Manual of international statistical classification of diseases, injuries and causes of death, IXth revision. Geneva: WHO; 1977.
3. •• Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13:1377-90. This is one of the first studies reporting normality values for 24-h ambulatory blood pressure values in the general population.
4. Sega R, Cesana G, Milesi C, et al. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension. 1997;30:1-6.
5. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-83.
6. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-87.
7. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104(12):1385-92.
8. •• Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54:226-32. The article provides evidence of the increased risk of white-coat and masked hypertension to develop a sustained hypertension and suggests that these conditions are not innocent from the prognostic point of view.
9. • Mancia G, Bombelli M, Facchetti R, et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens. 2009;27:1672-8. The article documents an increased risk of white-coat and masked hypertension to develop a condition of deranged glucose metabolism and suggests the importance of out-of-office blood pressure measurement in the prognostic stratification of hypertensive subjects.
10. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846-53.
11. Mancia G, Facchetti R, Bombelli M, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension. 2005;45:1072-7.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-7.
13. Mancia G, Bombelli M, Corrao G, et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension. 2007;49:40-7.
14. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens. 2008;26:1602-11.
15. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Arterioscler Thromb Vasc Biol. 2004;24:e13-8.
16. Alberti KG, Zimmet PZ, Shaw JE. The metabolic syndrome: a new worldwide definition from the International Diabetes Federation consensus. Lancet. 2005;366:1059-62.
17. Mancia G, Bombelli M, Facchetti R, et al. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. J Hypertens. 2010;28:999-1006.
18. Bombelli M, Facchetti R, Fodri D, et al. Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study. Nutr Metab Cardiovasc Dis. 2013, In press.
19. Bombelli M, Facchetti R, Sega R, et al. Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage. Hypertension. 2011;58:1029-35.
20. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-6.
21. Bombelli M, Facchetti R, Carugo S, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens. 2009;27:2458-64.
22. Poppe KK, Edgerton Bachmann M, Triggs CM, et al. Geographic variations in left ventricular mass and left ventricular mass index: a systematic review. J Hum Hypertens. 2012;26:420-9.
23. • Cuspidi C, Facchetti R, Sala C. Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study. J Hypertens. 2012;30:997-1003. This is the first study deriving the normalcy values of left ventricular mass from the mean values of a healthy population, without the confounding influence of overweight, obesity, diabetes mellitus, and clinical and out-of-office hypertension.
24. Wild PS, Sinning CR, Roth A, et al. Distribution and categorization of left ventricular measurements in the general population. Results from the population-based Gutenberg heart study. Circ Cardiovasc Imaging. 2010;3:604-13.
25. Lang RM, Bierig M, Devereux RB, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-63.